Market Overview:
The global implantable neurostimulator market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of neurological disorders, technological advancements in implantable neurostimulators, and rising demand for minimally invasive surgeries. Based on type, the global implantable neurostimulator market is segmented into deep brain stimulators (DBS), spinal cord stimulators (SCS), vagal nerve stimulators (VNS), sacral nerve stimulators (SNS), and gastric stimulators. The DBS segment is expected to account for the largest share of the global implantable neurostimulator market in 2018. This can be attributed to its high efficacy in treating various neurological disorders such as Parkinson’s disease, essential tremor, dystonia, and obsessive-compulsive disorder. Based on application, the global implantable neurostimulator market is segmented into Parkinson’s disease, epilepsy, pain management, and other applications.
Product Definition:
An implantable neurostimulator is a device that is surgically implanted in the body to deliver electrical stimulation to specific areas of the brain, spinal cord, or peripheral nerves. The stimulator may be used to treat conditions such as chronic pain, Parkinson's disease, epilepsy, and various types of incontinence.
Deep Brain Stimulators:
A deep brain stimulator is a medical device used to deliver electrical stimulation to the basal ganglia of the brain. It is implanted in the patient’s body and helps in treating various neurological disorders such as Parkinson's disease, dystonia, essential tremor, epilepsy and Alzheimer’s disease. The increasing prevalence of these diseases has led to an increase in research activities for finding effective treatment methods which have resulted into development of DBS devices.
Spinal Cord Stimulators:
A spinal cord stimulator is a medical device that sends regular and mild electrical impulses to the brain to control pain. It works by reducing or eliminating pain signals from traveling up the spine and reaching the brain. A spinal cord stimulator may be used for treatment of chronic back pain, neuropathic pain, failed back syndrome, radicular (nerve) disorder or other forms of acute painful events in the body.
Application Insights:
The Parkinson¢â‚¬â„¢s disease segment dominated the global market in 2017. The segment is expected to witness lucrative growth during the forecast period owing to increasing prevalence of PD, which results in high demand for DBS therapy. According to a study published by WHO, it was estimated that approximately 60 million people were affected by PD worldwide as of 2016 and around 1.5 million individuals were diagnosed with the condition that same year. Furthermore, according to data published by ULCA Neurosurgery on March 2018, over 3,000 patients from across Europe are diagnosed with PD every year and around 250 die due to complications associated with surgery.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, high disposable income, and favorable reimbursement policies & regulatory reforms. The region is expected to maintain its dominance throughout the forecast period owing to factors such as technological advancements and increasing prevalence of chronic diseases like Parkinson’s disease (PD), epilepsy, and pain. In addition, rising demand for minimally invasive surgeries is also anticipated to drive growth in this region.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to factors such as improving healthcare infrastructure & availability of treatment options at affordable costs coupled with growing patient awareness levels regarding these devices/treatments across various applications like neurological disorders or diabetes & obesity).
Growth Factors:
- Increasing prevalence of chronic diseases such as Parkinson's disease, Alzheimer's disease, and epilepsy is expected to drive the demand for implantable neurostimulators over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth owing to increasing incidence of neurological disorders in this population.
- Technological advancements in implantable neurostimulator devices are expected to provide lucrative opportunities for market growth over the next few years.
- Rising awareness about benefits of implantable neurostimulators is projected to propel demand for these devices in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Neurostimulator Market Research Report
By Type
Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators
By Application
Parkinson’s Disease, Epilepsy, Pain
By Companies
Medtronic, Boston Scientific, Abbott, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Neurostimulator Market Report Segments:
The global Implantable Neurostimulator market is segmented on the basis of:
Types
Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson’s Disease, Epilepsy, Pain
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott
- Cyberonics
- NeuroPace
- Synapse Biomedical
- NeuroSigma
- ReShape Lifesciences
- ElectroCore Medical
- Inspire Medical
- NEUROS
- SPR
- IMTHERA
- NEVRO
Highlights of The Implantable Neurostimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagal Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Stimulators
- By Application:
- Parkinson’s Disease
- Epilepsy
- Pain
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Neurostimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An implantable neurostimulator (INS) is a medical device that stimulates the brain. INSs are used to treat conditions such as epilepsy, depression, and chronic pain.
Some of the major players in the implantable neurostimulator market are Medtronic, Boston Scientific, Abbott, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO.
The implantable neurostimulator market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Neurostimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Neurostimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Neurostimulator Market - Supply Chain
4.5. Global Implantable Neurostimulator Market Forecast
4.5.1. Implantable Neurostimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Neurostimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Neurostimulator Market Absolute $ Opportunity
5. Global Implantable Neurostimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Neurostimulator Market Size and Volume Forecast by Type
5.3.1. Deep Brain Stimulators
5.3.2. Spinal Cord Stimulators
5.3.3. Vagal Nerve Stimulators
5.3.4. Sacral Nerve Stimulators
5.3.5. Gastric Stimulators
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Neurostimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Neurostimulator Market Size and Volume Forecast by Application
6.3.1. Parkinsons Disease
6.3.2. Epilepsy
6.3.3. Pain
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Neurostimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Neurostimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Neurostimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Neurostimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Neurostimulator Demand Share Forecast, 2019-2026
9. North America Implantable Neurostimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Neurostimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Neurostimulator Market Size and Volume Forecast by Application
9.4.1. Parkinsons Disease
9.4.2. Epilepsy
9.4.3. Pain
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Neurostimulator Market Size and Volume Forecast by Type
9.7.1. Deep Brain Stimulators
9.7.2. Spinal Cord Stimulators
9.7.3. Vagal Nerve Stimulators
9.7.4. Sacral Nerve Stimulators
9.7.5. Gastric Stimulators
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Neurostimulator Demand Share Forecast, 2019-2026
10. Latin America Implantable Neurostimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Neurostimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Neurostimulator Market Size and Volume Forecast by Application
10.4.1. Parkinsons Disease
10.4.2. Epilepsy
10.4.3. Pain
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Neurostimulator Market Size and Volume Forecast by Type
10.7.1. Deep Brain Stimulators
10.7.2. Spinal Cord Stimulators
10.7.3. Vagal Nerve Stimulators
10.7.4. Sacral Nerve Stimulators
10.7.5. Gastric Stimulators
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Neurostimulator Demand Share Forecast, 2019-2026
11. Europe Implantable Neurostimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Neurostimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Neurostimulator Market Size and Volume Forecast by Application
11.4.1. Parkinsons Disease
11.4.2. Epilepsy
11.4.3. Pain
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Neurostimulator Market Size and Volume Forecast by Type
11.7.1. Deep Brain Stimulators
11.7.2. Spinal Cord Stimulators
11.7.3. Vagal Nerve Stimulators
11.7.4. Sacral Nerve Stimulators
11.7.5. Gastric Stimulators
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Neurostimulator Demand Share, 2019-2026
12. Asia Pacific Implantable Neurostimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Neurostimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Neurostimulator Market Size and Volume Forecast by Application
12.4.1. Parkinsons Disease
12.4.2. Epilepsy
12.4.3. Pain
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Neurostimulator Market Size and Volume Forecast by Type
12.7.1. Deep Brain Stimulators
12.7.2. Spinal Cord Stimulators
12.7.3. Vagal Nerve Stimulators
12.7.4. Sacral Nerve Stimulators
12.7.5. Gastric Stimulators
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Neurostimulator Demand Share, 2019-2026
13. Middle East & Africa Implantable Neurostimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Neurostimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Neurostimulator Market Size and Volume Forecast by Application
13.4.1. Parkinsons Disease
13.4.2. Epilepsy
13.4.3. Pain
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Neurostimulator Market Size and Volume Forecast by Type
13.7.1. Deep Brain Stimulators
13.7.2. Spinal Cord Stimulators
13.7.3. Vagal Nerve Stimulators
13.7.4. Sacral Nerve Stimulators
13.7.5. Gastric Stimulators
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Neurostimulator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Implantable Neurostimulator Market: Market Share Analysis
14.2. Implantable Neurostimulator Distributors and Customers
14.3. Implantable Neurostimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cyberonics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NeuroPace
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Synapse Biomedical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NeuroSigma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ReShape Lifesciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ElectroCore Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Inspire Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NEUROS
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. SPR
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. IMTHERA
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. NEVRO
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
